Report on recent progress of chronic lymphocytic leukemia in the 53rd annual meeting of American Society of Hematology

( views:264, downloads:0 )
Author:
WU Wei(Department of Hematology, Jiangsu Province Hospital, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China)
XU Wei(Department of Hematology, Jiangsu Province Hospital, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China)
LI Jian-yong(Department of Hematology, Jiangsu Province Hospital, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China)
Journal Title:
Journal of Leukemia & Lymphoma
Issue:
Volume 21, Issue 01, 2012
DOI:
10.3760/cma.j.issn.1009-9921.2012.01.003
Key Word:
Leukemia, lymphocytic, chronic;ASH annual meeting

Abstract´╝Ü Chronic lymphocytic leukemia (CLL), the most frequent form of leukemia in Western countries, is characterized by the clonal proliferation and accumulation of neoplastic B lymphocytes in the blood,bone marrow,lymph nodes and spleen.During the past decades,important advances have been made in the understanding of the biology,pathology,diagnosis and treatment of CLL.In the 53rd ASH annual meeting,lots of new discoveries about the biology, prognosis, and treatment of CLL were introduced which lead us to further understand CLL and may provide more or better treatments for CLL patients.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn